89 related articles for article (PubMed ID: 12846495)
1. A phase II study of carboplatin and vinorelbine in patients with poor prognosis small cell lung cancer.
Mackay HJ; O'Brien M; Hill S; Lees SM; Thatcher N; Smith IE; Dunlop DJ
Clin Oncol (R Coll Radiol); 2003 Jun; 15(4):181-5. PubMed ID: 12846495
[TBL] [Abstract][Full Text] [Related]
2. Carboplatin plus vinorelbine, a new well-tolerated and active regimen for the treatment of extensive-stage small-cell lung cancer: a phase II study. Gruppo Oncologico Centro-Sud-Isole.
Gridelli C; Perrone F; Ianniello GP; Brancaccio L; Iaffaioli RV; Curcio C; D'Aprile M; Cioffi R; Cigolari S; Rossi A; Palazzolo G; Veltri E; Pergola M; De Placido S; Gallo C; Monfardini S; Bianco AR
J Clin Oncol; 1998 Apr; 16(4):1414-9. PubMed ID: 9552045
[TBL] [Abstract][Full Text] [Related]
3. Phase II study of oral vinorelbine in combination with carboplatin followed by consolidation therapy with oral vinorelbine as single-agent in unresectable localized or metastatic non-small cell lung carcinoma.
Reck M; Macha HN; Del Barco S; Cornes P; Vaissière N; Morand M; Riggi M; Abratt R
Lung Cancer; 2009 Jun; 64(3):319-25. PubMed ID: 19095327
[TBL] [Abstract][Full Text] [Related]
4. Vinorelbine in combination with carboplatin followed by single-agent consolidation therapy for unresectable localized or metastatic non-small-cell lung carcinomas.
Alici S; Coskun U; Alkis N; Sevinc A; Dane F; Gumus M; Ozkan M; Kaya AO; Celenkoglu G; Buyukberber S; Altunbas M; Benekli M;
Asian Pac J Cancer Prev; 2009; 10(6):1051-5. PubMed ID: 20192582
[TBL] [Abstract][Full Text] [Related]
5. Vinorelbine alternating oral and intravenous plus carboplatin in advanced non-small-cell lung cancer: results of a multicentre phase II study.
O'Brien ME; Szczesna A; Karnicka H; Zatloukal P; Eisen T; Hartmann W; Kasan P; Longerey B; Lefresne F
Ann Oncol; 2004 Jun; 15(6):921-7. PubMed ID: 15151949
[TBL] [Abstract][Full Text] [Related]
6. Cisplatin/carboplatin + etoposide + vinorelbine in advanced non-small-cell lung cancer: a multicentre randomised trial. Gruppo Oncologico Campano.
Comella P; Frasci G; De Cataldis G; Panza N; Cioffi R; Curcio C; Belli M; Bianco A; Ianniello G; Maiorino L; Della Vittoria M; Perchard J; Comella G
Br J Cancer; 1996 Dec; 74(11):1805-11. PubMed ID: 8956797
[TBL] [Abstract][Full Text] [Related]
7. Vinorelbine and carboplatin in inoperable non-small cell lung cancer: a monoinstitutional phase II study.
Cremonesi M; Mandalà M; Cazzaniga M; Rezzani C; Gambera M; Barni S
Oncology; 2003; 64(2):97-101. PubMed ID: 12566905
[TBL] [Abstract][Full Text] [Related]
8. Oral vinorelbine and cisplatin as induction chemotherapy and concomitant chemo-radiotherapy in stage III non-small cell lung cancer: final results of an international phase II trial.
Krzakowski M; Provencio M; Utracka-Hutka B; Villa E; Codes M; Kuten A; Henke M; Lopez M; Bell D; Biti G; Merimsky O; Beorchia A; Riggi M; Caux NR; Pouget JC; Dubray B; David P
J Thorac Oncol; 2008 Sep; 3(9):994-1002. PubMed ID: 18758302
[TBL] [Abstract][Full Text] [Related]
9. Carboplatin plus vinorelbine plus G-CSF in elderly patients with extensive-stage small-cell lung cancer: a poorly tolerated regimen. Results of a multicentre phase II study.
Gridelli C; Rossi A; Barletta E; Panza N; Brancaccio L; Cioffi R; Pedicini T; Ianniello GP; Piazza E; Rossi N; Iaffaioli RV; Maione P; Di Maio M; Gallo C; Perrone F
Lung Cancer; 2002 Jun; 36(3):327-32. PubMed ID: 12009246
[TBL] [Abstract][Full Text] [Related]
10. Carboplatin, ifosfamide, and vinorelbine in the treatment of advanced non-small-cell lung cancer: a phase II study.
Recchia F; Lococo A; Campisi C; Lalli A; Di Lullo L; De Filippis S; Vaccarili M; Zappalà A; Corrao G; Rea S
Am J Clin Oncol; 1999 Feb; 22(1):57-61. PubMed ID: 10025382
[TBL] [Abstract][Full Text] [Related]
11. Mitomycin C, vinblastine, and carboplatin regimen in patients with nonsmall cell lung cancer. A phase II trial.
Paccagnella A; Favaretto A; Oniga F; Festi G; Lauro S; Morabito A; Ossana L; Sartore F; DePoli F; Fiorentino MV
Cancer; 1996 Oct; 78(8):1701-7. PubMed ID: 8859183
[TBL] [Abstract][Full Text] [Related]
12. Second-line treatment with vinorelbine and carboplatin in patients with advanced non-small cell lung cancer. A multicenter phase II study.
Agelaki S; Bania H; Kouroussis C; Blazoyiannakis G; Souglakos J; Tsiafaki X; Kalbakis K; Rapti A; Androulakis N; Georgoulias V; Papadakis E
Lung Cancer; 2001 Dec; 34 Suppl 4():S77-80. PubMed ID: 11742708
[TBL] [Abstract][Full Text] [Related]
13. Concurrent radiochemotherapy with vinorelbine plus cisplatin or carboplatin in patients with locally advanced non-small-cell lung cancer (NSCLC) and an increased risk of treatment complications. Preliminary results.
Semrau S; Bier A; Thierbach U; Virchow C; Ketterer P; Fietkau R
Strahlenther Onkol; 2003 Dec; 179(12):823-31. PubMed ID: 14652671
[TBL] [Abstract][Full Text] [Related]
14. Carboplatin and vinorelbine in the treatment of advanced non-small-cell lung cancer: a multicenter phase II study.
Santomaggio C; Tucci E; Rinaldini M; Algeri R; Righi R; Pepi F; Ghezzi P; Andrei A; Bellezza A
Am J Clin Oncol; 1998 Feb; 21(1):67-71. PubMed ID: 9499262
[TBL] [Abstract][Full Text] [Related]
15. Low dose carboplatin (AUC 4.5) combined with vinorelbine in the treatment of advanced non-small cell lung cancer: a single institution phase II study.
Bretti S; Manzin E; Celano A; Ritorto G; Loddo C; Berruti A
Oncol Rep; 2001; 8(2):381-5. PubMed ID: 11182060
[TBL] [Abstract][Full Text] [Related]
16. Phase I and II trials of vinorelbine with carboplatin for patients 75 years of age or older with previously untreated non-small-cell lung cancer.
Takatani H; Nakamura Y; Nagashima S; Soda H; Kinoshita A; Fukuda M; Fukuda M; Soejima Y; Kasai T; Nakatomi K; Iida T; Oka M; Tsukamoto K; Kohno S
Clin Lung Cancer; 2012 Sep; 13(5):347-51. PubMed ID: 22264660
[TBL] [Abstract][Full Text] [Related]
17. Vinorelbine (Navelbine)/carboplatin combination therapy: dose intensification with granulocyte colony-stimulating factor.
Crawford J; O'Rourke MA
Semin Oncol; 1994 Oct; 21(5 Suppl 10):73-8. PubMed ID: 7526467
[TBL] [Abstract][Full Text] [Related]
18. A phase I-phase II study of vinorelbine with cisplatin, 5-fluorouracil, and leucovorin for advanced non-small cell lung cancer.
Masters GA; Drinkard LC; Hoffman PC; Lane N; Watson S; Samuels BL; Bitran JD; Golomb HM; Vokes EE
Cancer J Sci Am; 1995; 1(4):288-94. PubMed ID: 9166490
[TBL] [Abstract][Full Text] [Related]
19. Preliminary report on a phase I study of ifosfamide and vinorelbine (navelbine) in advanced non-small cell lung cancer.
Masters GA; Hoffman PC; Drinkard LC; Watson S; Samuels BL; Golomb HM; Vokes EE
Semin Oncol; 1996 Apr; 23(2 Suppl 5):11-8. PubMed ID: 8610230
[TBL] [Abstract][Full Text] [Related]
20. A dose-escalating study of carboplatin combined with vinorelbine in non-small-cell lung cancer.
Colleoni M; Boni L; Vicario G; Pancheri F; Sgarbossa G; Nelli P; Calabrò F; Toniolo L; Bortolotti L; Manente P
Oncology; 1996; 53(5):364-8. PubMed ID: 8784469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
